CDK4/6 inhibitors and endocrine therapies induce senescence with drug- and cell line-specific vulnerabilities in ERĪ±+ breast cancer (#114)
Lena Batoon
1
,
Angelo J Guilatco
1
,
Anna Detry
1
,
Xiyin Wang
1
,
Megan M Weivoda
1
,
John R Hawse
1
- Mayo Clinic, Rochester, MN, United States